22 October 2024
22 October 2024
iRhythm received a warning letter from the FDA in May 2024, citing violations of the United States Federal Food, Drug, and Cosmetic Act.
This capital injection will expedite the development and commercialisation of Okami's catheter-based technologies for peripheral vascular occlusion.
As a companion diagnostic, Oncomine will be used to identify patients eligible for treatment with Servier’s Voranigo.
The Caristo Diagnostics study found that the use of its artificial intelligence driven system was also able to significantly cut down on costs.
The first patient has been successfully imaged, marking a milestone in the development of this copper-based radiopharmaceutical.
The Farawave NAV ablation catheter and the Faraview software are used with the Farapulse field ablation system to provide visualisation for cardiac ablation procedures.
With 23andme in a desperate situation and eyeing a potential sale, Medical Device Network examines what is set to happen to the DNA data of millions of users.
The study is seen as critical in evaluating the safety and efficacy of the SCD for adults with AKI in ICUs.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
